Kusal K Das., Nima Razzaghi-Asl, Swati N Tikare, Roberto Di Santo, Roberta Costi, Antonella Messore, Luca Pescatori, Giuliana Cuzzucoli Crucitti, Jameel G Jargar, Salim A Dhundasi, Luciano Saso.
(BLDE(Deemed to be University), 2015)
The currently available therapies for type 2 diabetes have been unable to achieve normoglycemic status in the majority of patients. The reason may be attributed to the limitations of the drug itself or its side effects. ...